Polarean gets new polariser order from Cincinnati Children's
![Polarean Imaging | Sharecast graphic / Josh White dl polarean imaging aim medical imaging mri xenon gas drug device combination technology logo](https://img3.s3wfg.com/web/img/images_uploaded/e/3/dl-polarean-imaging-aim-medical-imaging-mri-xenon-gas-drug-device-combination-technology-logo_620x350.jpg)
Polarean Imaging
1.68p
16:55 06/09/24
Polarean Imaging announced a new polariser order to replace the research polariser at Cincinnati Children's Hospital Medical Center on Friday.
FTSE AIM All-Share
744.00
17:09 06/09/24
Health Care Equipment & Services
11,903.89
16:44 06/09/24
The AIM-traded firm said Cincinnati Children's, ranked as the top children's hospital in the United States for 2023-2024 by US News & World Report, previously acquired the first clinical polariser, and was dedicated to advancing Xenon MRI for challenging lung diseases.
It said the hospital conducts clinical imaging for both children and adults, including patients from their partner institution, UC Medical Centre.
Under the leadership of Dr Jason Woods, Cincinnati Children's operates a research programme centred on the Xenon MRI platform technology.
“I commend the ongoing work of the entire team at Cincinnati Children's, both in research and clinical care,” said Polarean chief executive officer Christopher von Jako.
“They consistently recognise the benefits that pulmonary functional Xenon MRI technology offers to children with chronic lung disease and have extended access to this technology to the adjacent adult hospital.
“We look forward to working closely with their team to ensure a swift implementation of the new system.”
At 1114 BST, shares in Polarean Imaging were down 0.77% at 3.62p.
Reporting by Josh White for Sharecast.com.